Universal hepatitis B vaccination: the economics of prevention.

par Krahn, M D, Detsky, A S
Publié 1992

Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen

par Krahn, M D, Coombs, A, Levy, I G
Publié 1999

Prostate cancer: 2. Natural history

par Nam, R K, Jewett, M A, Krahn, M D
Publié 1998

Prostate cancer: 12. The economic burden

par Grover, S A, Zowall, H, Coupal, L, Krahn, M D
Publié 1999

Direct and indirect costs of asthma in Canada, 1990.

par Krahn, M D, Berka, C, Langlois, P, Detsky, A S
Publié 1996

Direct health-care costs attributed to hip fractures among seniors: a matched cohort study

par Nikitovic, M., Wodchis, W. P., Krahn, M. D., Cadarette, S. M.
Publié 2012

Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events

par Krahn, M.D., Bremner, K.E., Luo, J., Alibhai, S.M.H.
Publié 2014

A160 ESTIMATION OF FIBROSIS PROGRESSION RATES FOR CHRONIC HEPATITIS C: UPDATED META-ANALYSIS AND META-REGRESSION

par Erman, A, Hansen, T, Bielecki, J M, Feld, J, Krahn, M D, Thein, R
Publié dans J Can Assoc Gastroenterol (2018)

Direct costs of coronary artery bypass grafting in patients aged 65 years or more and those under age 65

par Naglie, G, Tansey, C, Krahn, M D, O'Rourke, K, Detsky, A S, Bolley, H
Publié 1999

Long-term health care costs for prostate cancer patients on androgen deprivation therapy

par Krahn, M.D., Bremner, K.E., Luo, J., Tomlinson, G., Alibhai, S.M.H.
Publié dans Curr Oncol (2016)

Population-based trends in systemic therapy use and cost for cancer patients in the last year of life

par Pataky, R.E., Cheung, W.Y., de Oliveira, C., Bremner, K.E., Chan, K.K.W., Hoch, J.S., Krahn, M.D., Peacock, S.J.
Publié dans Curr Oncol (2016)